CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
WSD +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04880655
NCT04880655N/ACompleted

A Randomized, Controlled Study Evaluating a Surfactant-based Wound Dressing for Tissue Salvage and Reduction in Surgical Burden

University of Tennessee·interventional·Posted May 11, 2021·Updated Oct 26, 2023

In Brief

A clinical study evaluating WSD and Dressed with bacitracin and petrolatum gauze for Burns and Partial-thickness Burn. Completed, enrolled 27 participants across 1 site.

Detailed Summary

The purpose of this study is to test the following hypotheses: 1. Early use of water-soluble surfactant dressing (WSD) on partial-thickness burn wounds will result in tissue salvage and reduce surgical burden. 2. Early use of WSD on partial-thickness burn wounds will result in faster healing. 3. Use of WSD on partial-thickness burn wounds will result in less painful wound care. 4. Early use of WSD on partial-thickness burn wounds will result in less infection. 5. Early use of WSD on partial-thickness burn wounds will result in lower hospital costs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMedline Industries

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 11, 2021
Enrollment StartAug 3, 2021
Primary CompletionOct 24, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 5.1 years ago

Interventions

WSDdevice

Post debridement and within 24 hours of injury, wound care and WSD applied daily

Dressed with bacitracin and petrolatum gauzedevice

Post debridement and within 24 hours of injury, wound care and dressing applied daily